Executive Summary Artificial Intelligence (AI) in Drug Discovery Market Size and Share Analysis Report
CAGR Value
The global artificial intelligence (AI) in drug discovery market was valued at USD 981.64 Million in 2024 and is expected to reach USD 1483.82 Million by 2032
The global Artificial Intelligence (AI) in Drug Discovery Market research report has incorporated the analysis...
Environmental and agricultural applications are expanding the scope of microbiome sequencing services.Soil and plant microbiome studies are improving crop productivity and sustainability strategies.These diverse applications are contributing to steady market expansion across multiple industries.
According to analysis by The Insight Partners, the Microbiome Sequencing Services Market size is...
The path to drug discovery is long, costly, and heavily reliant on meticulous analysis of tissue samples during preclinical and clinical trials. Digital pathology image analysis software, especially that integrated with AI, is dramatically streamlining this process, offering drug developers an unprecedented level of quantitative insight into a drug’s mechanism of action and efficacy.
In...
The pharmaceutical industry in 2025 has undergone a massive transformation, with virtual clinical trials becoming a standard part of the drug development lifecycle. By simulating how a new compound interacts with thousands of virtual patients, researchers can identify potential side effects and efficacy concerns much earlier in the process. The Healthcare Digital Twin Arena enables "in silico"...
Introduction
The Artificial Intelligence in Drug Discovery Market is transforming the global pharmaceutical landscape by reshaping how new therapies are identified, designed, and developed. This field brings together advanced computational technologies with biological and chemical sciences, enabling drug developers to accelerate research timelines, improve accuracy, and reduce the risks...
Introduction
The Artificial Intelligence in Drug Discovery Market is transforming the global pharmaceutical landscape by reshaping how new therapies are identified, designed, and developed. This field brings together advanced computational technologies with biological and chemical sciences, enabling drug developers to accelerate research timelines, improve accuracy, and reduce the risks...
Executive Summary Asia-Pacific Artificial Intelligence (AI) in Drug Discovery Market Size and Share Across Top Segments
CAGR Value
Data Bridge Market Research analyzes that the Asia-Pacific Artificial Intelligence (AI) in drug discovery market is expected to reach the value of USD 3,424.04 million by 2029, at a CAGR of 50.9% during the forecast period.
Analysis and discussion of...
The Blue biotechnology is transforming industries by leveraging marine-derived resources for applications across pharmaceuticals, agriculture, energy, and environmental solutions. As the global focus shifts toward sustainability, the utilization of marine organisms such as algae, seaweed, and other bioactive compounds has become increasingly significant. These resources offer eco-friendly...
How is digitalization transforming pharmaceutical R&D?
The pharmaceutical industry has been a primary adopter of digital pathology, utilizing it to streamline preclinical trials and biomarker discovery. Digital slides allow for the use of complex spatial biology techniques, where researchers can map the interaction between immune cells and tumor cells in high detail.
In 2024, the focus has...
In-Depth Study on Executive Summary Europe Artificial Intelligence (AI) in Drug Discovery Market Size and Share
CAGR Value
Data Bridge Market Research analyzes that the Europe Artificial Intelligence (AI) in drug discovery market is expected to reach the value of USD 4,891.95 million by 2029, at a CAGR of 52.0% during the forecast period.
All statistical and numerical data is...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt